HistoSonics
Develops non-invasive sonic beam therapy for destroying targeted tumors.
medical-devices
Company facts
- Founded
- 2009
- Employees
- 357
- Headquarters
- United States
- Type
- Private
- Funding
- Series E · $250M · 2025
Open positions
1 job
5 views 3 weeks ago
Sr. Manager, Strategic Marketing - Abdominal Indications
Open 18d North AmericaFull-timeSenior
United States
Plymouth, MNHistoSonics is a commercial-stage medtech company advancing the Edison® System, a novel non-invasive sonic beam therapy based on histotripsy. Since receiving FDA De Novo grant for the non-invasive destruction of liver…
Analytics Business Intelligence Data Analytics Go-to-Market Sales Enablement